FedCircuitBlog

Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today’s report highlights:

• an article about how the “Federal Circuit refused . . . to rehear a challenge to a Delaware judge’s probe into the financing of patent litigation”;
• another article about “Sanofi and Regeneron on Friday urg[ing] the U.S. Supreme Court to reject Amgen’s arguments that it deserves broad patent coverage on cholesterol drugs”; and
• a blog post examining the reasons why the “Federal Circuit has ordered [Google’s] case moved out of the Western District of Texas (Waco) to the Northern District of California.”

Here is an update on recent en banc activity at the Federal Circuit in patent cases. The court denied three petitions raising questions related to attorney-client privilege, anticipation, and the standard for establishing venue. Here are the details.

Here is this month’s update on activity in cases pending before panels of the Federal Circuit where the cases involve at least one amicus brief. We keep track of these cases in the “Other Cases” section of our blog. Today, with respect to these cases we highlight six new cases, three of which involve petitions for writs of mandamus that were ultimately denied by the Federal Circuit. Additionally, we highlight an opinion in a government contract case and a patent case with a new briefing. Here are the details.

Here is an update on recent en banc activity at the Federal Circuit in patent cases. The court received a new petition raising a question related to the attorney-client privilege. The court also denied a petition in a case raising questions related to the standard for claim construction. Here are the details.

Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today’s report highlights:

• a blog post about the Federal Circuit “den[ying] a petition for writ of mandamus asking the Delaware district court to vacate an order to produce certain documents” related to third party funding in patent case; and
• an article about “Pfizer and BioNTech[‘s] . . . countersuit, demanding a jury trial and refuting Moderna’s claims of infringement” of patents related to COVID-19 vaccines.

Today, the Federal Circuit released two precedential opinions, one in a government contract case appealed from the Court of Federal Claims and one in a patent case appealed from the Patent Trial and Appeal Board. The Federal Circuit also released four nonprecedential opinions in cases appealed from the Merit Systems Protection Board, an arbitrator, and the Court of Appeals for Veterans Claims. The Federal Circuit also released two nonprecedential orders, two summary affirmances, and one dismissal. Here are the introductions to the opinions and links to the summary affirmances and dismissal.